199 related articles for article (PubMed ID: 12631334)
1. Posttransplant erythrocytosis.
Vlahakos DV; Marathias KP; Agroyannis B; Madias NE
Kidney Int; 2003 Apr; 63(4):1187-94. PubMed ID: 12631334
[TBL] [Abstract][Full Text] [Related]
2. Early posttransplant erythrocytosis in renal allograft recipients.
Prakash J; Singh S; Behur SK; Ghosh B; Sharatchandra LK; Dwivedi US
J Assoc Physicians India; 2010 Sep; 58():574-6. PubMed ID: 21391381
[TBL] [Abstract][Full Text] [Related]
3. [Post-transplant erythrocytosis].
Mustapić Z; Basić-Jukić N; Lovcić V; Kes P
Acta Med Croatica; 2011; 65(4):331-6. PubMed ID: 22359905
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA
Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant erythrocytosis: an enigma revisited.
Gaston RS; Julian BA; Curtis JJ
Am J Kidney Dis; 1994 Jul; 24(1):1-11. PubMed ID: 8023814
[TBL] [Abstract][Full Text] [Related]
6. Erythrocytosis after renal transplantation: review of 101 cases.
Einollahi B; Lessan-Pezeshki M; Nafar M; Pour-Reza-Gholi F; Firouzan A; Farhangi F; Pourfarziani V
Transplant Proc; 2005 Sep; 37(7):3101-2. PubMed ID: 16213319
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant erythrocytosis after kidney transplantation: A review.
Alzoubi B; Kharel A; Machhi R; Aziz F; Swanson KJ; Parajuli S
World J Transplant; 2021 Jun; 11(6):220-230. PubMed ID: 34164297
[TBL] [Abstract][Full Text] [Related]
8. Expression of angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocytosis.
Gupta M; Miller BA; Ahsan N; Ulsh PJ; Zhang MY; Cheung JY; Yang HC
Transplantation; 2000 Oct; 70(8):1188-94. PubMed ID: 11063339
[TBL] [Abstract][Full Text] [Related]
9. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.
Wang AY; Yu AW; Lam CW; Yu LM; Li PK; Goh J; Lui SF
Am J Kidney Dis; 2002 Mar; 39(3):600-8. PubMed ID: 11877580
[TBL] [Abstract][Full Text] [Related]
10. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
[TBL] [Abstract][Full Text] [Related]
11. Are the native kidneys responsible for erythrocytosis in renal allorecipients?
Dagher FJ; Ramos E; Erslev AJ; Alongi SV; Karmi SA; Caro J
Transplantation; 1979 Dec; 28(6):496-8. PubMed ID: 390790
[TBL] [Abstract][Full Text] [Related]
12. Post-renal transplant erythrocytosis: a case report.
Almonte M; Velásquez-Jones L; Valverde S; Carleton B; Medeiros M
Pediatr Transplant; 2015 Feb; 19(1):E7-10. PubMed ID: 25418869
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
[TBL] [Abstract][Full Text] [Related]
14. Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins.
Brox AG; Mangel J; Hanley JA; St Louis G; Mongrain S; Gagnon RF
Transplantation; 1998 Oct; 66(8):1053-8. PubMed ID: 9808491
[TBL] [Abstract][Full Text] [Related]
15. Postrenal transplant erythrocytosis: a review of 53 patients.
Wickre CG; Norman DJ; Bennison A; Barry JM; Bennett WM
Kidney Int; 1983 May; 23(5):731-7. PubMed ID: 6348369
[TBL] [Abstract][Full Text] [Related]
16. Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers.
Vishnu P; Moreno Vanegas Y; Wadei HM; Rivera CE
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29954763
[TBL] [Abstract][Full Text] [Related]
17. Erythrocytosis after renal transplantation. A prospective analysis.
Sumrani NB; Daskalakis P; Miles AM; Sarkar S; Markell MS; Hong JH; Friedman EA; Sommer BG
ASAIO J; 1993; 39(1):51-5. PubMed ID: 8439681
[TBL] [Abstract][Full Text] [Related]
18. Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis.
Glicklich D; Kapoian T; Mian H; Gilman J; Tellis V; Croizat H
Transplantation; 1999 Jul; 68(1):62-6. PubMed ID: 10428268
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism.
Danovitch GM; Jamgotchian NJ; Eggena PH; Paul W; Barrett JD; Wilkinson A; Lee DB
Transplantation; 1995 Jul; 60(2):132-7. PubMed ID: 7624954
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of contributing factors of post transplant erythrocytosis in renal transplant patients.
Ahmed S; Ahmed E; Naqvi R; Qureshi S
J Pak Med Assoc; 2012 Dec; 62(12):1326-9. PubMed ID: 23866484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
